Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Deutsche Bank AG (USA) (DB) Anymore

Page 1 of 2

The worries about the economic slowdown in China and the ongoing uncertainty about the path of interest-rate increases triggered several waves of equity sell-offs during the third quarter. Of course, most hedge funds and other asset managers had to stomach substantial losses during the bloody three-month period, which might have caused some to consider fleeing the U.S. equity markets. Interestingly, smaller-cap stocks registered higher losses than large-capitalization stocks during the September quarter, suggesting that institutional investors heavily discarded seemingly riskier equities amid high uncertainty and turmoil. In fact, the Russell 2000 Index lost 11.9% in the third quarter, while the Standard and Poor’s 500 benchmark declined a mere 6.4%. This article will lay out and discuss the hedge fund and institutional investor sentiment towards Deutsche Bank AG (USA) (NYSE:DB).

Deutsche Bank AG (USA) (NYSE:DB) has experienced a decrease in activity from the world’s largest hedge funds in recent months. Deutsche Bank AG (USA) (NYSE:DB) was in 8 hedge funds’ portfolios at the end of September. There were 12 hedge funds in our database with Deutsche Bank AG (USA) (NYSE:DB) positions at the end of the previous quarter. Its stock lost 10.61% value in the third quarter, keeping the market sentiment in alignment with the mood of the hedgies. For an in-depth understanding of the hedge fund behavior, we decided to cover hedge funds that had investments in Deutsche Bank AG (USA) (NYSE:DB), at the end of the September quarter.

The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Anthem Inc (NYSE:ANTM), Public Storage (NYSE:PSA), and PowerShares QQQ Trust, Series 1 (ETF) (NASDAQ:QQQ) to gather more data points.

Follow Deutsche Bank Ag (NYSE:DB)
Trade (NYSE:DB) Now!

If you’d ask most market participants, hedge funds are seen as underperforming, old financial tools of years past. While there are greater than 8000 funds trading today, we choose to focus on the top tier of this group, around 700 funds. These hedge fund managers manage the majority of the hedge fund industry’s total asset base, and by monitoring their top equity investments, Insider Monkey has spotted various investment strategies that have historically outstripped the market. Insider Monkey’s small-cap hedge fund strategy defeated the S&P 500 index by 12 percentage points annually for a decade in their back tests.

With all of this in mind, let’s check out the new action encompassing Deutsche Bank AG (USA) (NYSE:DB).

What have hedge funds been doing with Deutsche Bank AG (USA) (NYSE:DB)?

Heading into Q4, a total of 8 of the hedge funds tracked by Insider Monkey were long this stock, a decrease of 33% from the second quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Crispin Odey’s Odey Asset Management Group has the largest position in Deutsche Bank AG (USA) (NYSE:DB), worth close to $69.5 million, accounting for 5.5% of its total 13F portfolio. Coming in second is HBK Investments, managed by David Costen Haley, which holds a $27 million call position; 0.3% of its 13F portfolio is allocated to the stock. Some other professional money managers that hold long positions include Matthew Hulsizer’s PEAK6 Capital Management, and Cliff Asness’ AQR Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!